Financhill
Back

Verastem Quote, Financials, Valuation and Earnings

Verastem Price Quote

$4.20
+0.00 (+-5.41%)
(Updated: December 21, 2024 at 5:53 AM ET)

Verastem Key Stats

Sell
45
Verastem (VSTM) is a Sell

Day range:
$4.19 - $4.55
52-week range:
$2.10 - $14.22
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
16.88%

Volume:
1.8M
Avg. volume:
1.1M
1-year change:
-46.01%
Market cap:
$186.7M
Revenue:
$0
EPS:
$-3.2

How Much Does Verastem Make?

Data Unavailable

Is Verastem Growing As A Company?

Data Unavailable

Verastem Stock Price Performance

  • Did Verastem Stock Go Up Last Month?
    Verastem share price went up by 10.69% last month
  • Did VSTM's Share Price Rise Over The Last Year?
    VSTM share price fell by -46.01% over the past 1 year

What Is Verastem 52-Week High & Low?

  • What Is Verastem’s 52-Week High Share Price?
    Verastem has traded as high as $14.22 over the past 52 weeks
  • What Is Verastem’s 52-Week Low Share Price?
    Verastem has traded as low as $2.10 over the past 52 weeks

Verastem Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Verastem?

Data Unavailable

Is Verastem Cash Flow Positive?

Data Unavailable

Verastem Return On Invested Capital

Data Unavailable

Verastem Earnings Date & Stock Price

  • What Is Verastem's Stock Price Today?
    A single share of VSTM can be purchased today for 4.20
  • What Is Verastem’s Stock Symbol?
    Verastem trades on the nasdaq under the ticker symbol: VSTM
  • When Is Verastem’s Next Earnings Date?
    The next quarterly earnings date for Verastem is scheduled on March 14, 2025
  • When Is VSTM's next ex-dividend date?
    Verastem's next ex-dividend date is December 22, 2024
  • How To Buy Verastem Stock?
    You can buy Verastem shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Verastem Competitors

  • Who Are Verastem's Competitors?
    Below is a list of companies who compete with Verastem or are related in some way:
    • Applied Therapeutics Inc (APLT)
    • iBio Inc (IBIO)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Palatin Technologies Inc (PTN)
    • Reviva Pharmaceuticals Holdings Inc (RVPH)

Verastem Dividend Yield

Data Unavailable

Verastem Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -7.32%
Revenue: 0% -100%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable